Filing search / Iovance Biotherapeutics, Inc. / "Tax" / Page 4

8-K

EX-10.1

p8bnbl9w7zbohmybv3wc

23 Sep 21

Departure of Directors or Certain Officers

4:49pm

424B5

0zbhc

9 Feb 21

Prospectus supplement for primary offering

6:45am

8-K

EX-1.1

0g4tg7k

9 Feb 21

Entry into a Material Definitive Agreement

6:01am

8-K

EX-10.1

hrg89i9dwqmh4r3nh3h

8 Feb 21

Entry into a Material Definitive Agreement

9:55pm

8-K

EX-99.1

b96sn0q

5 Nov 20

Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020

4:05pm

8-K

EX-99.2

hzy90su kk29

5 Oct 20

Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer October 2020

5:15pm

8-K

EX-99.1

x6wovsdf4v 53pqp

5 Oct 20

Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer October 2020

5:15pm

8-K

EX-99.1

w4012wb8np2mghscd1uk

6 Aug 20

Iovance Biotherapeutics Reports Second Quarter 2020 Financial Results

4:05pm